Status:
COMPLETED
Host Response to Infection and Treatment in Lymphatic Filarial Disease in India
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Lymphatic Filarial Disease
Eligibility:
All Genders
18-75 years
Brief Summary
Patients admitted on this protocol will have, or be suspected of having, one of the lymphatic filarial infections affecting humans. After routine clinical evaluation they will be studied in depth immu...
Detailed Description
This study is designed to determine the presence of and the immune response to filarial and stronglyloides infections in an area endemic for both infections in South India. This study will aim to exam...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age 18-75 years.
- Ability to give informed consent.
- EXCLUSION CRITERIA:
- Pregnant or nursing women will be excluded from the treatment arm of the study.
- Less than 18 years of age; greater than 75 years of age.
Exclusion
Key Trial Info
Start Date :
April 23 1994
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2019
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00342576
Start Date
April 23 1994
End Date
July 15 2019
Last Update
July 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tuberculosis Research Centre
Chennai, India